NUVECTIS PHARMA INC (NVCT)
US67080T1088 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to NVCT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 22.44. This target is 340% above the current price.
NVCT was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about NVCT.
In the previous month the buy percentage consensus was at a similar level.
NVCT was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-07 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-07-13 | Ladenburg Thalmann | Initiate | Buy |
| 2022-05-10 | HC Wainwright & Co. | Maintains | Buy |
| 2022-03-02 | HC Wainwright & Co. | Initiate | Buy |